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ABSTRACT:
Objective To establish the acceptability and feasibility 
of delivering the Active Communication Education (ACE) 
programme to increase quality of life through improving 
communication and hearing aid use in the UK National 
Health Service.
Design Randomised controlled, open feasibility trial with 
embedded economic and process evaluations.
Setting Audiology departments in two hospitals in two UK 
cities.
Participants Twelve hearing aid users aged 18 years or 
over who reported moderate or less than moderate benefit 
from their new hearing aid.
Interventions Consenting participants (along with a 
significant other) were to be randomised by a remote, 
centralised randomisation service in groups to ACE plus 
treatment- as- usual (intervention group) or treatment- as- 
usual only (control group).
Primary outcome measures The primary outcomes 
were related to feasibility: recruitment, retention, treatment 
adherence and acceptability to participants and fidelity of 
treatment delivery.
Secondary outcome measures International Outcomes 
Inventory for Hearing Aids, Self- Assessment of 
Communication, EQ- 5D- 5L and Short- Form 36. Blinding of 
the participants and facilitator was not possible.
Results Twelve hearing aid users and six significant 
others consented to take part. Eight hearing aid users were 
randomised: four to the intervention group; and four to 
treatment- as- usual only. Four significant others participated 
alongside the randomised participants. Recruitment to the 
study was very low and centres only screened 466 hearing 
aid users over the 15- month recruitment period, compared 
with the approximately 3500 anticipated. Only one ACE 
group and one control group were formed. ACE could be 
delivered and appeared acceptable to participants. We were 
unable to robustly assess attrition and attendance rates due 
to the low sample size.
Conclusions While ACE appeared acceptable to hearing 
aid users and feasible to deliver, it was not feasible to 
identify and recruit participants struggling with their 
hearing aids at the 3- month posthearing aid fitting point.
Trial registration number ISRCTN28090877.
INTRODUCTION
Age- related hearing impairment is reported 
as the third most common chronic condition 
affecting approximately 328 million (91%) 
middle and older aged adults worldwide1 
and 10 million adults in the UK2 3 with the 
majority having mild or worse hearing impair-
ment, which progressively deteriorates with 
age.4 Hearing loss often impacts on quality 
of life and general well- being5–7 such as 
increased occurrences of depression,8 social 
isolation,7 poor social interactions,9–11 and 
cognitive dysfunction,12 as well as increased 
risk of developing dementia.13 In addition the 
impact on normally hearing significant others 
(SOs) living with hearing- impaired people, is 
often overlooked where similar problems are 
reported.9 14–17
In spite of robust evidence that hearing 
aid (HA) use reduces the negative impact 
of age- related hearing impairment on 
quality- of- life,5 18–20 it is estimated that up to 
Strengths and limitations of this study
 ► This is the first study to explore the potential of using 
Active Communication Education (ACE) as a tool to 
improve communication and hearing aid benefit for 
struggling adult hearing aid users and their signifi-
cant others.
 ► This is the first study to identify and evaluate the 
processes needed to deliver an randomised con-
trolled trial of treatment- as- usual plus ACE versus 
treatment- as- usual alone within audiology clinics.
 ► Low recruitment meant some of the trial objectives 
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30% of UK adult HA owners do not use them regularly 
or at all.3 21–23 The reasons behind this are complex.24 
Numerous barriers and facilitators to successful HA 
use have been identified as being related to expec-
tations of benefit and meaningful participation in 
everyday life.25 26
The Active Communication Education (ACE) 
programme27 trains participants to develop solutions 
to specific difficult communication scenarios that 
commonly lead to their avoidance of, or reduced 
participation in, daily activities. Three small studies 
have demonstrated benefits in improving communica-
tion function and hearing related quality of life when 
evaluated as an alternative to HA fitting.28–30 However, 
the effect of ACE on improving HA benefit when deliv-
ered in addition to HA fitting has not been evaluated. 
The ACE To HEAR study (ACE To improve HEARing) 
aimed to assess whether a large randomised controlled 
trial (RCT) to evaluate the effectiveness and cost- 
effectiveness of ACE plus treatment- as- usual (TAU) 
versus TAU alone, was feasible within UK National 
Health Service (NHS) audiology departments.
DESIGN AND METHODS
The methods are summarised below and published in 
more detail elsewhere.31 This was an open feasibility RCT 
with embedded economic and process evaluations. The 
required regulatory approvals were in place prior to study 
commencement.
Setting
The participating centres were York Hospital, York 
Teaching Hospitals NHS Foundation Trust, and Bradford 
Royal Infirmary, Bradford Teaching Hospitals NHS Foun-
dation Trust.
Intervention
TAU was defined as a referral from a general practi-
tioner (GP) to audiology services to treat permanent 
hearing loss. It comprised up to two appointments 
for HA fitting and a third face- to- face or telephone 
follow- up appointment. The ACE To HEAR inter-
vention consisted of five group sessions delivered as 
described in the published ACE manual27 by a trained 
audiologist facilitator to groups of 5–7 HA users and 
their SOs, where possible.
Study objectives
The study objectives were established around evaluating 
the delivery of the ACE intervention and the feasibility of 
trial delivery to assess:
 ► Trial up- take rates, eligibility, and acceptability of 
clinic location.
 ► Recruitment rates, the randomisation process and 
time to accrue ACE groups.
 ► ACE attendance and retention among participants 
randomised to the intervention group.
 ► Acceptability of ACE with participants, SOs and 
audiologists.
 ► Capability, capacity and willingness of audiology 
departments to support delivery of ACE within 
existing services;
 ► Intervention fidelity of delivering ACE.
 ► The acceptability of study processes to participants, 
SOs and audiologists.
 ► Patient- reported outcome measures (PROMs) 
including piloting a bespoke resource use ques-
tionnaire and estimate parameters to be used when 
designing full- scale RCT.
Sample size and randomisation
Since this was a feasibility trial, no formal power 
calculation was conducted. We aimed to recruit 88 
HA users aged 18 years or over receiving TAU in the 
two participating centres, along with their SOs. The 
full eligibility criteria can be found in the published 
protocol.31 The study sites estimated that there would 
be approximately 400 new HA fitted across the study 
centres each month. Assuming 10% eligibility, 35% 
did not attend (DNA) and 30% consent rate, around 
350 cases per month across the two centres would 
have needed to be screened to recruit the required 88 
HA users in 12 months.
In the initial months of the trial (April to August 2017), 
eligibility criteria had included Q1 and Q2 from the 
International Outcomes Inventory for HA (IOI- HA).32 
Q1 required self- reported HA use of less than 3 hours a 
day and Q2 required less than moderate benefit for eligi-
bility. However, early scrutiny of the Q1 recruitment data 
showed evidence of over reported HA use, including a 
variable presence of confirmatory HA log data and it was 
therefore removed as a criterion. Q2 was also reviewed 
and considered too stringent; eligibility was changed to 
include moderate as well as less than moderate benefit as 
these HA users were also considered to be struggling. 
These changes were implemented as of 29 August 2017.
Eligible, consenting HA users from the same study 
site who had completed baseline assessments were to be 
randomised 1:1 by a remote, centralised randomisation 
service (provided by York Trials Unit) in batches of 10–14 
using block randomisation in a single large block per 
batch. This was to allow groups of 5–7 to be formed for the 
ACE intervention sessions. The target was to randomise 
participants within 3 weeks of consent.
Measurements
Data collected from participants at baseline via 
self- completed questionnaires were: IOI- HA;32 Self- 
Assessment of Communication (SAC)33; EuroQol-5 
Dimensions(5- level) Questionnaire (EQ- 5D- 5L)34 35 
and Short- Form 36 (SF-36),36 resource use and demo-
graphics. SOs completed baseline questionnaires 
collecting: demographics; IOI- HA: version for SOs 
(IOI- HA- SO)37 and Significant Other Scale for 
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Those in the ACE group also completed a question-
naire at the end of ACE session five. Measures were 
IOI- HA and the IOI for Alternative Interventions (IOI- 
AI).38 Their SOs completed IOI- HA- SO, SOS- HEAR, and 
the IOI- AI- SO.37
The TAU participants were mailed questionnaires 
containing the IOI- HA at the equivalent time point; with 
their SOs completed IOI- HA- SO and SOS- HEAR. Partic-
ipants and their SOs were asked additional questions 
regarding their thoughts on the programme (ACE arm 
only) and being approached to take part in the study 
(both arms). The facilitator collected data during all 
five ACE sessions in relation to participants’ attendance 
at sessions, SO attendance and their relationship to 
participant.
At 3 months postrandomisation both groups (ACE and 
TAU) and their SOs completed the same measures as at 
baseline, and those in the ACE group and their SOs also 
completed the IOI- AI and associated IOI- AI- SO.
The feasibility and the potential for a future large- scale 
study was to be determined by a set of stop: go criteria 
(table 1).
Statistical analysis
A single analysis was conducted at the end of the trial 
and undertaken in Stata V.15. Baseline and outcome data 
for HA users are summarised overall and by randomised 
group, and are reported as mean, SD, median, minimum 
and maximum for continuous data, and counts and 
percentages for categorical data. The amount of missing 
data for each variable is also reported.
The recruitment rate is summarised by month, overall, 
and by site. Attendance at the ACE sessions by partici-
pants and their SOs are detailed.
Questionnaire return rates at each time point are 
presented overall and by group. It was planned that SDs 
would be presented for PROMs with 80% CIs to inform 
future sample size calculations. An analysis to investigate 
sensitivity of the measures to change, by calculating the 
standardised response mean, was also planned.
The number of participants withdrawing from the ACE 
intervention and/or the trial and any reasons for with-
drawal are summarised.
Economic analysis and quality of life data
The present trial aimed to determine the feasibility of 
conducting an economic evaluation of the ACE to HEAR 
intervention taking a broad perspective accounting 
not only for NHS costs but also those observed by HA 
users. In the UK, National Institute for Health and Care 
Excellence (NICE) advocates the use of the EQ- 5D for 
measuring quality of life; however, the EQ- 5D is not 
always the most sensitive tool for particular populations 
for whom the majority of its dimensions may not apply.39 
In a US analysis of a similar population, the SF-36 was 
used to generate QALYs rather than the EQ- 5D, with the 
SF-36 showing a reduction in the cost per QALY in favour 
of the intervention.28 Given the UK preference for the 
EQ- 5D, and the fact that it is shorter, thus less onerous to 
complete, participants in the feasibility trial were asked 
to complete both instruments to allow for comparison. 
Completion rates and mean scores for both instruments 
are summarised.
A bespoke resource use questionnaire was also designed 
to estimate the potential resource implications of the 
intervention versus usual care. Completion rates and 
mean resource use by item are summarised.
Process evaluation
The number of ACE sessions delivered was recorded 
and, to assess fidelity of delivering ACE, the facilitator 
completed a self- monitoring form, scoring adherence to 
the ACE manual for each session.
Table 1 Stop: go criteria
Criteria Measure
Seventy per cent of recruitment targets attained for all 
research components
Numbers referred; numbers struggling with their hearing aid; no of exclusions.
Study consent/retention rates and proposed sample 
sizes, indicate delivery of the full RCT is plausible 
within a 5- year study period
Numbers screening; numbers consenting; numbers who declined to 
participate and reasons for declining; numbers withdrawing.
Ninety per cent of ACE groups of five to seven 
consented participants formed within the intervention 
window with participants attending three of five 
sessions
Time taken to recruit and logistics of recruiting an optimally sized and located 
ACE group; time ACE started after randomisation (ACE intervention window). 
Number of consented participants who failed to attend ACE sessions; no who 
missed ACE intervention window (ie, unable to attend an ACE group within 
1–3 weeks after randomisation).
Economic, acceptability, outcome measure and fidelity 
evaluation data successfully collect
Amount of missing data, although measures with over 10% missing data may 
be modified/replaced prior to the main trial.
Participants, SOs and audiologists evaluate 
acceptability of the ACE and RCT positively
Number given an appointment for an ACE group session; number of 
consented participants who failed to attend ACE sessions; facilitator’s 
adherence to the ACE protocol (fidelity); participant and SO thoughts 
regarding the study (interviews).
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Following delivery of all the sessions, the facilitator 
was interviewed to explore the training and implemen-
tation process and their experiences of delivering ACE 
including barriers/facilitators to adhering to the ACE 
protocol. In addition, three audiologists were inter-
viewed, exploring the capability, capacity and willingness 
of their audiology departments to support the ACE study 
within their existing services. The acceptability of study 
processes were also explored.
Three participants in the ACE intervention group, plus 
one SO, were interviewed after the completion of the 
ACE sessions. The semistructured interviews explored the 
acceptability of the ACE (eg, venue, timing, content), its 
perceived impact (reflecting on HA outcomes) as well as 
exploration of participant’s views on study processes (eg, 
recruitment, outcome measures and timing).
Interviews were audiorecorded, transcribed verbatim 
and analysed (with NVivo V.11), using the Framework 
approach,40 and then interpreted by team members.
Patient and public involvement
The development of this research study was informed by 
a variety of patient and public involvement (PPI) activ-
ities. A funded public engagement event about public 
perceptions of hearing impairment helped inform the 
research question as participants identified a need for 
wider availability of treatments in addition to HA espe-
cially non- technological interventions, such as commu-
nication education. This feedback led to the choice of 
an interactive communication- based intervention rather 
than an informational one and reinforced the need to 
ensure that routine practical information about HA 
and hearing impairment is delivered consistently and 
checked after fitting. A focus group was then held to 
consult with service users on the proposed research ques-
tion, study design and intervention delivery including 
study information and consent procedures, barriers and 
facilitators to participation, communication scenarios 
and motivating factors to becoming more active commu-
nicators. In addition, the charity Hearing Link, who have 
extensive experience of PPI and managing and deliv-
ering group interventions of this type, were consulted 
about involving public and patients in operationalising 
and delivering ACE. The formation of a project advisory 
panel consisting of service users ensured PPI involvement 
continued during the conduct of this study. Patients were 
not directly involved in recruitment to the study. A lay 
summary of the findings will be sent to the participants 
as well as disseminated via patient forums, Trust bulletins 
and public interest groups.
RESULTS
Recruitment
The flow of participants through the trial is shown in 
a Consolidated Standards of Reporting Trials diagram 
(figure 1). Screening and recruitment occurred from 
1 April 2017 to the end of June 2018; 466 HA users 
were screened while attending a follow- up HA fitting 
appointment at Bradford (n=275) or contacted by 
telephone 3 months postfitting at York (n=191). Of 
these, 86 (18.5%) were eligible but 74 declined to 
participate. Twelve participants were recruited into 
the trial (14.0% of those eligible); 1 from Bradford 
and 11 from York (online supplemental figure 1 in 
online supplemental material 1). Reasons for ineligi-
bility (n=380) and non- consent (n=74) can be found 
in figure 1. The most common reason was that the HA 
helped too much (81.8% of n=380 excluded). Six SOs 
also consented to take part.
It was found that 22.6% of HA users who were 
screened (n=380) were eligible (based on the appli-
cable screening criteria at the time of screening; 
additional participants were identified as ‘would 
have been eligible’ when the inclusion criteria were 
changed); however, on average only 33 HA users were 
screened each month, and this was confounded by the 
13.9% consent rate (% of the 86 eligible, 8.9% when 
including those who would have been eligible under 
the new criteria).
Randomisation
Randomisation was intended to be performed in 
batches of 10–14 participants. However, due to slow 
recruitment, the decision was made in January 2018 to 
randomise the participants recruited from York thus 
far as a smaller block to allow at least one ACE group 
to be run. The randomisation was undertaken as a 
block of eight, four participants to each group. Addi-
tionally, four SOs were also recruited, and allocated 
to their respective participant’s group—three to TAU 
and one to the intervention group. There were insuf-
ficient numbers of participants to randomise the four 
subsequently recruited participants, and the two SOs.
The average time from screening to randomisa-
tion was 19.5 weeks (range 10.6–33.6 weeks) and the 
target 3- week window for randomisation post- consent 
was missed for all participants. If the group had been 
randomised immediately after the eighth participant 
was consented (randomisation was delayed in the 
hope of a larger group), then the average time would 
have been 8.9 weeks, with 37.5% meeting the 3- week 
target. The first ACE session was conducted 11 days 
after randomisation.
Participants
The baseline characteristics of randomised partici-
pants and their SOs can be found in table 2. As there 
was only one SO in the intervention group, data are 
only presented overall to prevent disclosure.
Online supplemental table 1 in the online supple-
mental material 1 shows the screening data on use 
and benefit of HA, threshold data and hearing loss 
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Participants had mild to moderately severe high 
frequency sensorineural hearing loss, except for one 
who reported an additional conductive element to their 
hearing loss. Five participants reported using their HA for 
less than 4 hours a day and three for more than 8 hours a 
day. All participants reported less than moderate levels 
of benefit. Those randomised to the ACE intervention 
reported that they had been concerned about their 
Figure 1 The flow of participants through the trial shown in a CONSORT diagram. ACE, active communication education; 
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hearing for markedly more years than those allocated to 
TAU.
Intervention attendance
Of the four York participants who were randomised to 
receive the intervention, one attended all five sessions, 
one attended four sessions, one three sessions and one 
participant did not attend any of the five sessions. This 
equates to an average attendance rate of 60%. Of these 
four participants, only one had an SO who wished to 
participate, and they attended all the sessions that their 
associated participant attended.
Follow-up and standardised measures
At the end of the sessions (approximately week 5), 7/8 
participants (87.5%) returned the postal questionnaire 
(ACE 4/4 (100%); TAU 3/4 (75%)). In addition, 3/4 
Table 2 Baseline characteristics for the randomised participants, by group and overall and overall for the SOs
ACE intervention 
participants (n=4) TAU participants (n=4) All participants (n=8) All SOs (n=4)
Age, years
  Mean (SD) 73.0 (7.8) 73.3 (6.0) 73.1 (6.4) 73.6 (7.3)
  Median (min, max) 72.9 (64.1, 82.1) 73.9 (65.9, 79.5) 73.6 (64.1, 82.1) 76.6 (62.9, 78.3)
Gender, n (%)
  Male 3 (75.0) 2 (50.0) 5 (62.5) 2 (50.0)
  Female 1 (25.0) 2 (50.0) 3 (37.5) 2 (50.0)
Length of time concerned about hearing, years
  Mean (SD) 21.3 (7.5) 3.5 (1.9) 12.4 (10.8) N/A
  Median (min, max) 20 (15, 30) 4 (1, 5) 10 (1, 30) N/A
Ethnicity, n (%)
  White British 4 (100.0) 4 (100.0) 8 (100.0) 4 (100.0)
  Other 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Marital status, n (%)
  Married/civil partner 2 (50.0) 3 (75.0) 5 (62.5) 4 (100.0)
  Separated 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Divorced 1 (25.0) 1 (25.0) 2 (25.0) 0 (0.0)
  Missing 1 (25.0) 0 (0.0) 1 (12.5) 0 (0.0)
Living arrangements, n (%)
  Owned outright 3 (75.0) 4 (100.0) 7 (87.0) 4 (100.0)
  Owned with mortgage 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Rented 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Privately rented 1 (25.0) 0 (0.0) 1 (12.5) 0 (0.0)
Main activity, n (%)
  Full- time employment 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Part time 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Self- employed 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Unable to work due to health 1 (25.0) 0 (0.0) 1 (12.5) 0 (0.0)
  Retired 2 (50.0) 4 (100.0) 6 (75.0) 4 (100.0)
  Student 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Retired and self- employed 1 (25.0) 0 (0.0) 1 (12.5) 0 (0.0)
Qualifications, n (%)
  No formal qualifications 2 (50.0) 1 (25.0) 3 (37.5) 0 (0.0)
  GCSEs 1 (25.0) 1 (25.0) 2 (25.0) 1 (25.0)
  A/AS levels 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Higher education 0 (0.0) 1 (25.0) 1 (12.5) 2 (50.0)
  Further higher education 0 (0.0) 1 (25.0) 1 (12.5) 0 (0.0)
  Vocational 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  Other 1 (25.0) 0 (0.0) 1 (12.5) 1 (12.5)











































































































7Watson J, et al. BMJ Open 2021;11:e043364. doi:10.1136/bmjopen-2020-043364
Open access
(75%) SOs returned their questionnaires (ACE 1/1 
(100%); TAU 2/3 (67%)).
At 3 months postrandomisation, the retention rate 
was 75%; three out of four participants from each group 
returned the questionnaires. Three of the four (75%) 
SOs returned their 3 months postrandomisation ques-
tionnaires. No participants withdrew in this study (but 
one participant in the ACE group did not attend a single 
session).
The results from online supplemental table 1 (online 
supplemental material 1), completed by the participants 
at both baseline and at least one of the follow- up time 
points, show that the measures used were well completed. 
The average IOI- HA score at all three time points was 
in the mid- to- high range, indicating average hearing 
outcomes; there was no obvious change in this result in 
either group over time. There does appear to be imbal-
ance in the SAC between TAU and ACE participants, with 
those in the control group rating themselves as being 
worse at communicating. However, as with the IOI- HA 
there appears to be no change in the average score across 
the follow- up period.
The outcome measures for the SOs were equally well 
completed (online supplemental table 1: online supple-
mental material 1). Since only one SO completed the 
IOI- AI- SO, the results are not presented.
Out of all of the returned questionnaires (n=8, 6 and 6 
for participants and n=4, 3 and 3 for SOs at baseline, W5 
and M6, respectively) there was only one instance where a 
PROM was not completed sufficiently to allow for scoring 
(IOI- AI for an ACE participant at M6).
The 80% CIs for SDs for PROMs were not calculated, 
and the planned analysis to investigate the sensitivity 
of the measures to change was not conducted as it was 
considered they would not produce reliable results due 
to the low sample size.
Health economics
Of the eight participants at baseline, all completed the 
EQ- 5D- 5L in full, compared with six full completions 
(75%) and two partial completions for the SF-36 (25%). 
At 3 months postrandomisation, two participants (one 
from each group) did not complete the questionnaire; all 
remaining participants completed both the EQ- 5D- 5L and 
SF-36 in full. At baseline, participants allocated to the inter-
vention group had a slightly higher mean score compared 
with participants in the TAU group (mean difference 0.057) 
(table 3). This difference was reversed at 3 months with 
participants allocated to the TAU group having a slightly 
higher mean score (mean difference −0.186); although as 
the sample size is small, no conclusions can be drawn from 
this.
These findings were also reflected in the results of the 
SF-36 (table 4). At baseline, participants allocated to the 
intervention group scored on average higher on dimensions 
of physical role, general health, social function, emotional 
role and mental health as well as on the overall physical and 
mental components. At the 3 months postrandomisation 
follow- up, participants allocated to the intervention group 
only scored higher on the measure of vitality.
The resource use questionnaire was not well completed, 
with one full completion (12.5%) and five partial comple-
tions (62.5%) at baseline and six partial completions only 
at 3 months postrandomisation (75%). There was no differ-
ence in completion by trial group. Overall, very low levels 
of resource use were reported across both groups with most 
resource use centred on hearing healthcare professionals 
(online supplemental table 1: online supplemental mate-
rial 1).
Appropriate unit costs to be applied for each resource 
use type were identified through local costings and national 
databases including Personal Social Services Research 




Five ACE sessions were delivered. At the first session, (1) 
introduction to ACE and communication needs anal-
ysis, the group decided which modules they wanted to 
use, since each addressed a different aspect of commu-
nication. They chose: conversation in background noise 
(session 2); conversation around the house (session 3); 
communication with difficult speakers (session 4) and 
public address systems (session 5). Three HA users and 
one SO attended.
Facilitator views and fidelity
Overall, the facilitator considered the ACE programme to 
have had a positive impact because some of the content 
was new knowledge for participants, and a few had 
reported implementing some communication strategies 
with success.
‘The information I was able to give I think was really 
positive and helped them a lot. I think having spoken to 
them the following week they’d been able to implement 
some of them (communication strategies) and found 
those quite useful. Particularly things like watching the 
TV at home, that they could put the subtitles on or could 
Table 3 EQ- 5D- 5L mean (SD) scores and mean difference at baseline and 3 months postrandomisation follow- up
Follow- up ACE mean (SD) TAU mean (SD) Mean difference (ACE- TAU)
Baseline 0.670 (0.333) 0.613 (0.512) 0.057
3 months postrandomisation 0.686 (0.411) 0.871 (0.133) −0.186
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change the sound settings or that kind of thing. I think 
they all felt a bit more empowered by the end of it, that 
they were able to admit that they had a hearing loss and 
admit that things weren’t going to be perfect in every 
situation.’
Key challenges to its delivery were low numbers of partic-
ipants which limited discussion, some reluctance among 
participants to ‘bother others’ to help with communica-
tion, and participants wanting to discuss HA technology 
and their frustrations with audiology services (instead of 
communication). As the sessions progressed, the facili-
tator became more flexible in delivering the programme, 
ensuring that these other topics were covered. This 
was reflected in the fidelity scores which changed from 
‘adherence to the protocol’ all the time (session 1), most 
of the time (sessions 2 and 3) and sometimes (sessions 4 
and 5).
Participants’ views
In reflecting on the ACE programme, two participants 
and one SO gave several examples of how it was helpful. 
They had tried out different strategies: sitting with their 
back to the wall, adjusting settings on their TV, using 
subtitles and checking if the loop system is switched on 
when visiting theatres. A key change was increased confi-
dence in speaking out when they cannot hear and asking 
others to help with this, for example; facing them when 
in conversation, requesting people to repeat themselves 
rather than speak more loudly and closing a window to 
reduce background noise.
‘It also brought it home to me how important it is to tell 
other people that you’ve got a hearing problem, because 
you’re reluctant to do it when you’re first deaf. And so 
you muddle along and you say ‘yes, yes’, and then some-
times you know that they’re getting annoyed so then you 
pretend to hear what was said and of course you laugh 
in the wrong place or you can’t join in the jokes. I always 
miss punchlines. So, I learned that you must say to people 
‘I’m sorry, I can’t hear, can I sit here? Can we do this? Can 
we turn that off?’
That said, there was still some reluctance to ask others 
for help, with participants favouring strategies that they 
could do themselves. One participant said he felt the 
training ‘wasn’t right for me’ and that the sessions had 
not changed anything for him.
Audiologists’ views
The audiologists said they had been able to deliver the 
study within their departments; adapting their routine 
follow- up process to include the ACE screening ques-
tionnaire. However, the study was more time consuming 
than anticipated and requiring extra support from the 
Table 4 SF-36 mean (SD) scores and mean difference at baseline and 3 months postrandomisation follow- up
SF-36 score ACE mean (SD) TAU mean (SD) Mean difference (ACE - TAU)
Baseline
  Physical functioning 61.67 (28.77) 66.25 (44.60) −4.58
  Physical role 54.69 (40.63) 48.44 (38.32) 6.25
  Bodily pain 59 (32.19) 65.33 (46.88) −6.33
  General health 61.5 (36.30) 49.75 (24.31) 11.75
  Vitality 45.31 (22.46) 52.08 (15.73) −6.77
  Social functioning 68.75 (33.07) 58.33 (50.52) 10.42
  Emotional role 77.08 (26.68) 77.08 (15.77) 0
  Mental health 68.75 (23.94) 63.33 (12.58) 5.42
  Overall physical component 41.11 (14.69) 39.44 (24.22) 1.67
  Overall mental component 46.87 (10.77) 45.86 (2.31) 1.01
3 months postrandomisation
  Physical functioning 45 (39.05) 83.33 (10.41) −38.33
  Physical role 41.67 (38.19) 68.75 (22.53) −27.08
  Bodily pain 66.67 (57.74) 70 (6.93) −3.33
  General health 58 (41.87) 58.67 (15.28) −0.67
  Vitality 54.17 (36.62) 52.08 (3.61) 2.08
  Social functioning 62.5 (45.07) 87.5 (21.65) −25
  Emotional role 75 (25.0) 88.89 (19.25) −13.89
  Mental health 78.33 (20.21) 78.33 (16.07) 0
  Overall physical component 36.10 (21.08) 45.84 (7.134) −9.74
  Overall mental component 51.33 (10.23) 51.67 (11.97) −0.34
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university team to help answer questions from HA users 
was mentioned in one department. Suggested reasons 
for the failure to recruit were: too strict eligibility criteria 
(which were changed); a reluctance of older people to 
participate in research; communication barriers are 
already discussed in routine appointments; and many 
HA users nowadays are younger and want to focus on 
the benefits that technology afford. Ideas for improving 
recruitment were: to recruit people at their initial fitting, 
or people who are long term HA users; offer more days 
and locations for follow- up appointments so more people 
attend; present ACE as a support group rather than 
a research study and send flyers out or invite potential 
participants in for a coffee morning to discuss the study.
Finally, in discussing trial processes, the facilitator and 
participants observed it had taken a long time to set up 
the first ACE group and that the information needed to 
be clearer that the focus of the programme was commu-
nication. Participants and audiologists mentioned the 
length and complexity of the ACE questionnaires. It was 
difficult to deliver these over the telephone with some 
elderly HA users.
DISCUSSION
This is the first study to explore the potential of ACE as a 
tool to improve communication and HA benefit for strug-
gling adult HA users and their SOs. It is also the first study 
to identify and evaluate the processes needed to deliver 
an RCT of ACE within the GP direct referral pathway for 
new NHS HA users in the UK (TAU). The key findings 
from this feasibility study are: (1) there is some (limited 
data) to suggest the intervention is potentially accept-
able and feasible to HA users, SOs and audiologists; (2) 
the data show that the data collection, monitoring and 
reporting aspects of the trial delivery were feasible and 
acceptable; finally, (3) we were unable to demonstrate the 
efficacy of recruitment to the trial within a NHS setting. 
We did, however, identify some problems that underpin 
the difficulty of recruitment in this context.
Recruitment to RCTs is challenging and it is important 
to report the root causes of recruitment difficulties so that 
mistakes are not repeated in future studies. Emerging 
data were explored by the trial team to consider how to 
problem solve and optimise recruitment and associated 
procedures.
The number of patients fitted with an HA who were 
followed up and screened for eligibility (n=466), was 
extremely low in comparison to the number of expected 
HA fittings (>4000). The study sites’ data reporting mech-
anisms struggled to accurately report the patient flow 
(monthly HA fittings) through this pathway but actual 
non- attendance rates for patients offered a follow- up 
appointment were calculated to be 30%, the level planned 
for, and do not account for this short fall.
During the study planning phase, both sites agreed to 
introduce face- to- face or telephone follow- up (not previ-
ously offered, despite NICE guidelines indicating this 
as good practice43) for all patients in the TAU pathway. 
The low number of patients seen for follow- up and then 
screened for eligibility by both sites suggests fully embed-
ding and scaling- up this change took longer in practice 
than anticipated. Not all patients in the pathway were 
offered post- fitting follow- up and not all who attended 
were screened, leading to a significantly smaller pool 
of potential participants to screen (problems also high-
lighted by Donovan et al44).
There is some evidence that RCTs with more restrictive 
eligibility criteria exhibit poorer recruitment than those 
with wider criteria.45 After 6 weeks of missed monthly 
recruitment targets, we reviewed our eligibility criteria. As 
noted previously, the relationship between daily hours of 
HA use and HA outcomes is not well specified.46 Conse-
quently, criterion Q1 (hours of use), was dropped and the 
level of benefit (Q2) criterion widened to include patients 
reporting moderate benefit. Audiologists’ feedback 
supported these changes and by the end of recruitment 
over 26% of those screened had identified as struggling. 
We had factored in a conservative estimate of 10%, based 
on clinical experience at each study site. The disparity 
reflects the modified eligibility criteria and variability in 
self- reported HA use data noted earlier.
Despite these problems, the screening process appeared 
to successfully identify the target population since the 
demographic profile of those screened and consented 
was as expected. The range of ages (64.1–82.1) indicated 
that it was older, not younger participants who were both 
eligible and willing to participant. Their hearing profile 
was consistent with that expected from struggling HA 
users.
Our a priori estimate (30%) of willing participants was 
closer to 14%. Since willingness is dependent on project 
specifics, population demographics and patient percep-
tions of the research’s value and worth, this was a feasi-
bility parameter of interest. We could find no relevant 
study reporting detailed recruitment statistics in this 
context for comparison.
Comparing our recruitment issues with earlier ACE 
studies27 29 is difficult since their context was very different, 
not least because they recruited from an already moti-
vated population, rather than a specific publicly funded 
pathway known to foster motivational challenges, as 
reported here. Descriptions of the burden associated with 
RCT participation include, anxiety about taking part in 
research, factors related to processing trial information, 
demanding follow- up and lack of appropriate post- trial 
management.47 Our patients were possibly already feeling 
overwhelmed by managing their new HA and were less 
motivated to engage in research. Of the eligible, non- 
consenting patients, the majority gave no reason, were 
not interested or were too busy. Hickson et al28 reported a 
much lower non- consent rate (20% compared with 86% 
here) and none of the burdens identified by Naidoo et 
al
47 were overtly apparent.
It is notable that patients’ decisions to not take part 
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the research nurse for further information and consent. 
Audiologists reported struggling to find time to answer 
participants’ questions fully (either by phone or face to 
face). Thus, the opportunity for prospective participants 
to process the trial information at this point may not 
have been optimum, and they declined referral to the 
Research Nurse. However, this was not reflected in the 
patients’ narrative on non- consenting.
Research involvement can also be burdensome for 
clinicians and time is a frequently voiced barrier to their 
participation in research.48 49 Pressures from usual clinical 
practice,48 50 time demands of recruitment and follow- up, 
leading to increases in workload pressure51 are associated 
with under- recruitment, as is a lack of research experi-
ence,48 52 which was something the interviews with the 
screening audiologists revealed as a critical concern.
During the project development, audiologists and 
service managers said they could adapt their practice to 
include ACE screening. However, over time, they consid-
ered the screening questionnaire to be onerous and one 
site felt that they required more help from the ‘university 
team’ to answer patient’s questions, despite having a dedi-
cated research nurse/practitioner on site.
It is unlikely that patients declined to participate 
because they thought the research unimportant since 
participant interviews and prestudy PPI work indicated 
our research question was perceived as important.
Important aspects of recruitment such as ensuring 
simple procedures for information provision and 
consenting, and that study- related follow- ups do not 
increase pressure on usual clinical follow- ups (either 
for clinicians or patients)52 53 were not really tested here 
because so few participants consented. Interviews with 
those who did indicated these aspects were not off- putting.
Many aspects of the study processes worked well. The 
randomisation process was viewed as acceptable by the 
small cohort recruited although insufficient numbers were 
achieved to allocate the last four participants recruited. 
There was no sense from the recruitment process that SO 
recruitment was problematic or that including SOs had 
a detrimental effect on recruitment. The SO/participant 
ratio (although from minimal data) is commensurate 
with similar studies15 28 and was viewed as a positive incen-
tive by participants. Having an SO was not an inclusion 
criterion, not disadvantaging those without an SO.
The trial processes undertaken for collecting outcome 
measures worked well. Outcome measure completion 
rates and interview data suggests that processes worked 
and are acceptable to participants. Due to insufficient 
participant numbers, estimation of SD for the PROMS, 
quality- of- life tools and healthcare resource use question-
naires was not possible. Completion and retention rates 
both indicate that while we were unable to recruit into 
the trial, those who were randomised stayed involved, 
suggesting a trial may have been possible had recruitment 
not been an issue. Attempts to increase recruitment via 
amendments to streamline recruitment paperwork and 
processes failed, and further study site training proved 
unsuccessful. We also planned to (1) add additional study 
sites; (2) change the point in the referral pathway at 
which HA users were approached, to the fitting appoint-
ment, rather than the 3 months follow- up appointment 
and (3) to transfer all responsibility for recruitment from 
the NHS audiologists to the university research team. 
Ethical approval was gained for these adjustments and the 
funder granted the additional time required, but refused 
additional funding.
The ACE delivery processes appeared to work well, 
with the facilitator becoming more flexible over the 
five sessions to accommodate participant’s needs within 
the ACE protocol. Participants mostly completed the 
programme and were generally positive in their feed-
back, citing changes they were making. This is in line 
with previous studies using ACE in Australia, Sweden and 
Chile.28 30 54 All previous studies reported good adherence 
to the ACE programme (>90% completed three or more 
of the five sessions), and positive outcomes were indicated 
in terms of communication. All studies found pre- ACE 
and post- ACE improvements in communication strategy 
use, particularly for those with mild hearing loss; activity 
and participation and psychosocial well- being, with find-
ings reflected in positive feedback. Despite the small 
numbers of participants in this current study, participants 
also reported positive benefits from completing the ACE 
programme. A key challenge to the efficacy of delivering 
ACE here was the small group sizes that limited group 
discussion, so it was interesting and encouraging to note 
the broad changes people made in their communication 
strategies because the ACE programme.
CONCLUSION
A future RCT using the recruitment strategy reported 
here is not likely to be feasible. The fundamental 
problem was in accessing sufficient struggling HA users 
at follow- up. Recruiting HA users when first fitted may 
be a better strategy for future research. Additional work 
to investigate which point in the pathway patients should 
best be approached and to identify the resources needed 
for good recruitment is required. Work to develop a 
robust service delivery model of follow- up for new adult 
HA users based on NICE guidelines will be crucial, as 
would implementing organisational support for NHS 
audiologists involved in research.
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